Published in Presse Med on August 29, 1970
The role of circulating hepatitis B antigen/antibody immune complexes in the pathogenesis of vascular and hepatic manifestations in polyarteritis nodosa. J Clin Pathol (1974) 2.85
Vasculitides associated with HIV infection. J Clin Pathol (2001) 1.32
Immune complexes of hepatitis B surface antigen in the pathogenesis of periarteritis nodosa. A study of seven necropsy cases. Am J Pathol (1978) 1.15
Extrahepatic manifestations of acute hepatitis B virus infection. Gastroenterol Hepatol (N Y) (2013) 0.93
Autoimmune manifestations in viral hepatitis. Semin Immunopathol (2012) 0.88
Complications of viral hepatitis. Can Med Assoc J (1972) 0.81
Kaleidoscope of autoimmune diseases in HIV infection. Rheumatol Int (2016) 0.79
Vasculitis. Bull N Y Acad Med (1979) 0.75
Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. N Engl J Med (1998) 6.23
The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol (1977) 3.07
A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C. Hepatology (2001) 3.02
Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B. Gastroenterology (2004) 2.97
Detection of hepatitis B virus DNA in liver and serum: a direct appraisal of the chronic carrier state. Lancet (1981) 2.80
Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours. Nature (1990) 2.61
Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research. Lancet (2000) 2.58
Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trial. Gastroenterology (1993) 2.32
Influence of delta infection on severity of hepatitis B. Lancet (1982) 2.31
Waterborne outbreak of intestinal microsporidiosis in persons with and without human immunodeficiency virus infection. J Infect Dis (1999) 2.20
A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group. N Engl J Med (1995) 2.06
Reactivity pattern of a monoclonal antikeratin antibody (KL1). J Invest Dermatol (1983) 1.98
Sensitivity and specificity of third-generation hepatitis C virus antibody detection assays: an analysis of the literature. J Viral Hepat (2001) 1.89
Experimental production of antibodies against stratum corneum keratin polypeptides. Arch Dermatol Res (1980) 1.87
Symptomatic relapse of neurologic syphilis after benzathine penicillin G therapy for primary or secondary syphilis in HIV-infected patients. Clin Infect Dis (2006) 1.77
Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation. Hepatology (1997) 1.74
Attempt to protect rabbits against experimental syphilis by passive immunization. Br J Vener Dis (1973) 1.68
Acquired protein S deficiency: correlation with advanced disease in HIV-1-infected patients. J Acquir Immune Defic Syndr (1992) 1.67
Serological pattern "anti-HBc alone": report on a workshop. J Med Virol (2000) 1.65
Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study. J Viral Hepat (2005) 1.64
Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma. Br J Cancer (2008) 1.59
Antikeratin antibodies in serum and synovial fluid show specificity for rheumatoid arthritis in a study of connective tissue diseases. Ann Rheum Dis (1985) 1.54
External anogenital lesions in organ transplant recipients. A clinicopathologic and virologic assessment. Arch Dermatol (1997) 1.53
Antinuclear autoantibodies in Swiss mice thymectomized at birth. Nature (1967) 1.50
Randomized controlled trial of adenine arabinoside 5'-monophosphate in chronic active hepatitis B: comparison of the efficacy in heterosexual and homosexual patients. Hepatology (1989) 1.50
PUVA-induced repigmentation of vitiligo: scanning electron microscopy of hair follicles. J Invest Dermatol (1980) 1.46
The HBV HBX gene expressed in E. coli is recognised by sera from hepatitis patients. EMBO J (1985) 1.45
Randomised, double-blind, placebo-controlled trial of ditiocarb sodium ('Imuthiol') in human immunodeficiency virus infection. Lancet (1988) 1.43
[Oral photochemotherapy in vitiligo (author's transl)]. Ann Dermatol Venereol (1979) 1.39
Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis. N Engl J Med (1981) 1.34
Role of immune complexes involving SH antigen in pathogenesis of chronic active hepatitis and polyarteritis nodosa. Lancet (1971) 1.30
Treatment of hepatitis C virus-related cirrhosis: a randomized, controlled trial of interferon alfa-2b versus no treatment. Hepatology (1999) 1.29
Clinical consequences of hepatitis C virus infection. Rev Med Virol (2003) 1.27
Intravenous vitamin complexes used in sporting activities and transmission of HCV in Brazil. Am J Gastroenterol (1999) 1.26
Identification of additional antigenic sites on Dane particles and the tubular forms of hepatitis B surface antigen. J Gen Virol (1976) 1.25
Hepatitis associated antigen and periarteritis nodosa (PAN). Vox Sang (1971) 1.23
Long-term follow-up of the hepatitis C HENCORE cohort: response to therapy and occurrence of liver-related complications. J Viral Hepat (2007) 1.21
Rapid detection of Pneumocystis carinii in bronchoalveolar lavage specimens from human immunodeficiency virus-infected patients: use of a simple DNA extraction procedure and nested PCR. J Clin Microbiol (1997) 1.20
Keratin polypeptides distribution in normal and diseased human epidermis and oral mucosa. Immunohistochemical study on unaltered epithelium and inflammatory, premalignant and malignant lesions. Virchows Arch A Pathol Anat Histol (1980) 1.18
Comparison of properties of woodchuck hepatitis virus and human hepatitis B virus endogenous DNA polymerases. Antimicrob Agents Chemother (1984) 1.18
Comparison of HIV detection by virus isolation in lymphocyte cultures and molecular amplification of HIV DNA and RNA by PCR in offspring of seropositive mothers. J Acquir Immune Defic Syndr (1991) 1.16
Comparison of transesophageal and transthoracic contrast echocardiography for detection of an intrapulmonary shunt in liver disease. Chest (1997) 1.15
Fulminant hepatitis with severe lactate acidosis in HIV-infected patients on didanosine therapy. J Intern Med (1994) 1.15
In vitro activity of 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]-pyrimidine against multidrug-resistant hepatitis B virus mutants. Antimicrob Agents Chemother (2007) 1.14
Detection of virus-associated antigen in serum and liver of patients with non-A non-B hepatitis. Lancet (1979) 1.14
Investigation of a specific IgM antibody test in neonatal congenital syphilis. Br J Vener Dis (1970) 1.14
Clinical relevance of total HCV core antigen testing for hepatitis C monitoring and for predicting patients' response to therapy. J Viral Hepat (2003) 1.12
Lectins as markers of human epidermal cell differentiation. Differentiation (1982) 1.12
Specific immunity in patients suffering from recurring warts before and after repetitive intradermal tests with human papilloma virus. Br J Dermatol (1977) 1.11
Measurement and determinants of the natural history of liver fibrosis in hepatitis C virus infection: a cross sectional and longitudinal study. Gut (2003) 1.11
Protective and therapeutic effect of DNA-based immunization against hepadnavirus large envelope protein. Gastroenterology (1999) 1.09
A prospective study of the evolution of lamivudine resistance mutations in patients with chronic hepatitis B treated with lamivudine. J Viral Hepat (2006) 1.09
Interleukin-6 in normal skin and psoriasis. Acta Derm Venereol (1992) 1.09
[Immunofluorescence studies of serum autoantibodies with respect to the constituents of the epidermis of burned patients]. Experientia (1968) 1.09
Progressive replacement of human cultured epithelial allografts by recipient cells as evidenced by HLA class I antigens expression. Dermatologica (1987) 1.08
Congenital self-healing histiocytosis (Hashimoto-Pritzker). An ultrastructural and immunohistochemical study. Cancer (1988) 1.07
Polyarteritis nodosa related to hepatitis B virus. A retrospective study of 66 patients. Ann Med Interne (Paris) (1992) 1.07
Inhibition of human and woodchuck hepatitis virus DNA polymerase by the triphosphates of acyclovir, 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine and E-5-(2-bromovinyl)-2'-deoxyuridine. Antiviral Res (1984) 1.07
Inhibitory effects of 2'-fluorinated arabinosyl-pyrimidine nucleosides on woodchuck hepatitis virus replication in chronically infected woodchucks. Antimicrob Agents Chemother (1990) 1.06
Langerhans cells in skin from patients with psoriasis: quantitative and qualitative study of T6 and HLA-DR antigen-expressing cells and changes with aromatic retinoid administration. J Invest Dermatol (1983) 1.06
Precocious appearance of involucrin and epidermal transglutaminase during differentiation of psoriatic skin. Br J Dermatol (1986) 1.05
Letter: Detection of e antigen by immunofluorescence in cytoplasm of hepatocytes of HBsAg carriers. Lancet (1976) 1.04
Plasma viraemia as a marker of viral replication in HIV-infected individuals. AIDS (1991) 1.02
Diagnostic value of amplification of human cytomegalovirus DNA from gastrointestinal biopsies from human immunodeficiency virus-infected patients. J Clin Microbiol (1993) 1.02
Fine mapping of neutralization epitopes on duck hepatitis B virus (DHBV) pre-S protein using monoclonal antibodies and overlapping peptides. Virology (1993) 1.01
Hepatitis C virus recurrence after liver transplantation. Gut (1999) 1.01
Clinical evaluation of a single reaction, diagnostic polymerase chain reaction assay for the detection of hepatitis C virus RNA. J Hepatol (1996) 1.00
Oral photochemotherapy in the treatment of lichen planus (LP). Clinical results, histological and ultrastructural observations. Br J Dermatol (1978) 1.00
[Scleroderma en coup de sabre with homolateral chronic glaucoma (author's transl)]. Ann Dermatol Venereol (1977) 1.00
Prevalence of intestinal protozoans in French patients infected with HIV. J Acquir Immune Defic Syndr (1993) 1.00
Immunocytochemical evidence for a possible role of cross-linked keratinocyte envelopes in stratum corneum cohesion. J Histochem Cytochem (1991) 1.00
Variable expression of preS1 antigen in serum during chronic hepatitis B virus infection: an accurate marker for the level of hepatitis B virus replication. Hepatology (1990) 0.99
PUVA-induced repigmentation of vitiligo: a histochemical (split-DOPA) and ultrastructural study. Br J Dermatol (1979) 0.99
Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol (1995) 0.98
Maintenance of woodchuck hepatitis virus activity in woodchuck hepatocyte primary culture. J Gen Virol (1987) 0.98
Analysis of HCV co-infection with occult hepatitis B virus in patients undergoing IFN therapy. J Clin Virol (2004) 0.97
Normal and psoriatic human skin grafts on "nude" mice: morphological and immunochemical studies. J Invest Dermatol (1981) 0.97
[Maternally-transmitted severe neonatal aphthosis]. Ann Dermatol Venereol (1982) 0.97
Morphological, immunological and immunocytochemical identification of lymphocytes extracted from cutaneous infiltrates. Clin Exp Immunol (1976) 0.97
CD4 antibody treatment of severe psoriasis. Lancet (1991) 0.96
Anti-D47: a monoclonal antibody reacting with the secretory cells of human eccrine sweat glands. Br J Dermatol (1983) 0.96
Lichen planus and chronic graft-versus-host reaction. In situ identification of immunocompetent cell phenotypes. J Cutan Pathol (1982) 0.96
In vitro mixed skin cell lymphocyte culture reaction (MSLR) in man: analysis of the epidermal cell and T cell subpopulations. Clin Exp Immunol (1982) 0.96
Paromomycin: an effective treatment for cryptosporidial diarrhea in patients with AIDS. Clin Infect Dis (1994) 0.95
Woodchuck hepatitis virus infection: serologic and histopathologic course and outcome. Eur J Clin Microbiol (1985) 0.95
Prolonged duck hepatitis B virus replication in duck hepatocytes cocultivated with rat epithelial cells: a useful system for antiviral testing. Hepatology (1989) 0.95
Anti-CD4 monoclonal antibody therapy in severe psoriasis. J Autoimmun (1992) 0.95
[Hepatitis B antigen (HB Ag and Australia antigen). Clinical value of its detection by solid phase radioimmunoassay (R.I.A.)]. Nouv Presse Med (1973) 0.95
Mutagenesis of ras proto-oncogenes in rat liver tumors induced by vinyl chloride. Cancer Res (1994) 0.95
Testing for HCV-RNA in commercial intravenous immunoglobulins. Lancet (1993) 0.94
Proficiency of transient elastography compared to liver biopsy for the assessment of fibrosis in HIV/HBV-coinfected patients. J Viral Hepat (2011) 0.94
[Contribution to the study of the treponeme isolated from monkeys by A. Fribourg-Blanc]. Bull World Health Organ (1969) 0.94
Immunohistochemical study of normal skin of HIV-1-infected patients shows no evidence of infection of epidermal Langerhans cells by HIV. AIDS Res Hum Retroviruses (1989) 0.94
Phosphorylation of DHBV pre-S: identification of the major site of phosphorylation and effects of mutations on the virus life cycle. Virology (1998) 0.94
Bullous dermatosis and myeloma. Monoclonal anticytoplasmic antibody activity. Arch Dermatol (1980) 0.94